A Study of Silmitasertib (CX-4945) in Healthy Subject
Clinical trial NCT05817708 · COMPLETED
Trial details
- NCT number
- NCT05817708
- Sponsor
- Senhwa Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-03-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.